Cargando…
Effect of Prucalopride in the Treatment of Chronic Constipation in Asian and Non-Asian Women: A Pooled Analysis of 4 Randomized, Placebo-controlled Studies
BACKGROUND/AIMS: To compare the efficacy and safety of prucalopride, a novel selective high-affinity 5-hydroxytryptamine type 4 receptor agonist, versus placebo, in Asian and non-Asian women with chronic constipation (CC). METHODS: Data of patients with CC, receiving once-daily prucalopride 2-mg or...
Autores principales: | Ke, MeiYun, Tack, Jan, Quigley, Eamonn M M, Zou, Duowu, Choi, Suck Chei, Leelakusolvong, Somchai, Liu, Andy, Kim, JinYong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Neurogastroenterology and Motility
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204404/ https://www.ncbi.nlm.nih.gov/pubmed/25273116 http://dx.doi.org/10.5056/jnm14029 |
Ejemplares similares
-
Factors Predictive of Treatment-Emergent Adverse Events of Prucalopride: An Integrated Analysis of Four Randomized, Double-Blind, Placebo-Controlled Trials
por: Leelakusolvong, Somchai, et al.
Publicado: (2015) -
Use of Prucalopride for Chronic Constipation: A Systematic Review and Meta-analysis of Published Randomized, Controlled Trials
por: Sajid, Muhammad S, et al.
Publicado: (2016) -
Response to letter: Balancing risks and benefits of prucalopride for the treatment of chronic constipation in Asians
por: Ke, M, et al.
Publicado: (2013) -
Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials
por: Camilleri, Michael, et al.
Publicado: (2016) -
Comparison of Placebo Effect between Asian and Caucasian Type 2 Diabetic Patients: A Meta-Analysis
por: Guo, Wei, et al.
Publicado: (2018)